Drugs Made In America Acquisition Corp. Ordinary Shares Defensive Interval Ratio
Drugs Made In America Acquisition Corp. Ordinary Shares defensive interval ratio. Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) has a Defensive Interval Ratio of 619 days as of December 2024. Defensive assets of $1.35K (cash $-, short-term investments $1.35K, receivables $-) cover 619 days of daily cash needs of $2.18/day. See working capital position of Drugs Made In America Acquisition Corp. to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of Drugs Made In America Acquisition Corp. Ordinary Shares (2024–2024)
Defensive interval ratio of Drugs Made In America Acquisition Corp. Ordinary Shares from 2024 to 2024. This chart shows how Drugs Made In America Acquisition Corp. Ordinary Shares's Defensive Interval Ratio has evolved across 1 annual periods from 2024 to 2024. As of December 2024, the ratio stands at 619 days, meaning defensive assets of $1.35K can fund 619 days of operations without new revenue. Read total liabilities of Drugs Made In America Acquisition Corp. for a breakdown of total debt and financial obligations.
Drugs Made In America Acquisition Corp. Ordinary Shares Defensive Interval Ratio by Year (2024–2024)
Drugs Made In America Acquisition Corp. Ordinary Shares defensive interval ratio by year from 2024 to 2024. The table below presents the year-by-year Defensive Interval Ratio for Drugs Made In America Acquisition Corp. Ordinary Shares from 2024 to 2024, covering 1 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see DMAA current and non-current assets.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 619 days | $1.35K | $2.18/day | $- | $1.35K | — |